JPRN-UMIN000042348招募中未知
Asian international randomised web-based study of education for detection of colorectal flat and depressed lesions - Detect flat and depressed colorectal polyp higher (CATCH) project 1
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 258
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 99years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Be already registered this study before. Be impossible to contact via e-mail. Violate the protocol
研究者
相似试验
尚未招募
Unknown
Evaluation of a Japanese encephalitis vaccine decision aid in adults travelling overseas to at-risk areasJapanese encephalitisVaccine decision-makingPublic Health - Health promotion/educationInfection - Other infectious diseasesACTRN12624001176550Monash University500
已完成
不适用
The CREDO Research Project: Can mood problems be prevented and treated using e-health interventions in patients being treated for cardiovascular disease?Cognitive functionMental Health - DepressionCardiovascular - Coronary heart diseaseMental Health - Studies of normal psychology, cognitive function and behaviourCardiovascular DiseaseDepressionACTRN12610000085077The University of Sydney500
进行中（未招募）
不适用
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated SyndromeMedDRA version: 14.0Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2009-013884-21-DEEnceladus Pharmaceuticals BV90
进行中（未招募）
1 期
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)EUCTR2009-013884-21-BEEnceladus Pharmaceuticals BV90
进行中（未招募）
不适用
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated SyndromeMedDRA version: 14.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2009-013884-21-PLEnceladus Pharmaceuticals BV90